Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13994 | 735 | 28.0 | 44% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TRIMETHADIONE | Author keyword | 8 | 52% | 1% | 11 |
2 | ZAKLAD CHEM FIZJOL | Address | 4 | 75% | 0% | 3 |
3 | ZAKLAD CHEM FIZJOLOGICZNEJ | Address | 4 | 75% | 0% | 3 |
4 | HEPATIC MICROSOMAL FUNCTION | Author keyword | 3 | 100% | 0% | 3 |
5 | TRIMETHADIONE TOLERANCE TEST | Author keyword | 3 | 100% | 0% | 3 |
6 | ANTIPYRINE | Author keyword | 3 | 11% | 3% | 24 |
7 | ANTIPYRINE CLEARANCE | Author keyword | 2 | 27% | 1% | 7 |
8 | WYDZIAL BIOTECHNOL HODOWLI ZWIERZAT | Address | 1 | 31% | 1% | 4 |
9 | HEPATIC OXIDIZING CAPACITY | Author keyword | 1 | 100% | 0% | 2 |
10 | FUNCTIONAL HEPATIC RESERVE | Author keyword | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DRUG OXIDIZING CAPACITY | 20 | 100% | 1% | 9 |
2 | 4 HYDROXYANTIPYRINE | 12 | 86% | 1% | 6 |
3 | NORANTIPYRINE | 11 | 100% | 1% | 6 |
4 | 4 4 DIHYDROXY ANTIPYRINE | 6 | 100% | 1% | 4 |
5 | USEFUL INDICATOR | 4 | 67% | 1% | 4 |
6 | PHENAZONE ANTIPYRINE | 4 | 75% | 0% | 3 |
7 | 3 METHYLCHOLANTHRENE TREATMENT | 4 | 56% | 1% | 5 |
8 | MODEL DRUG | 4 | 26% | 2% | 12 |
9 | METABOLITE FORMATION | 2 | 20% | 1% | 11 |
10 | ANTIPYRINE TEST | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
ANTIPYRINE AS A MODEL-DRUG TO STUDY HEPATIC DRUG-METABOLIZING CAPACITY | 1988 | 118 | 41 | 73% |
DRUGS AND THE LIVER .2. THE ROLE OF THE ANTIPYRINE TEST IN DRUG-METABOLISM STUDIES | 1991 | 45 | 55 | 67% |
THE RELATIONSHIP BETWEEN PHENAZONE (ANTIPYRINE) METABOLITE FORMATION AND THEOPHYLLINE METABOLISM IN HEALTHY AND FRAIL ELDERLY WOMEN | 1993 | 7 | 20 | 55% |
INTERINDIVIDUAL VARIATIONS IN DRUG DISPOSITION - CLINICAL IMPLICATIONS AND METHODS OF INVESTIGATION | 1983 | 98 | 14 | 71% |
Trimethadione: Metabolism and assessment of hepatic drug-oxidizing capacity | 1996 | 1 | 10 | 80% |
ANTIPYRINE AS A MODEL-DRUG TO ASSESS OXIDATIVE DRUG-METABOLIZING ACTIVITY IN MAN | 1984 | 33 | 11 | 91% |
IDENTIFICATION OF PATIENTS WITH IMPAIRED HEPATIC DRUG-METABOLISM USING A LIMITED SAMPLING PROCEDURE FOR ESTIMATION OF PHENAZONE (ANTIPYRINE) PHARMACOKINETIC PARAMETERS | 1993 | 17 | 22 | 27% |
USE OF ANTIPYRINE TEST FOR STUDYING DRUG MICROSOMAL OXIDATION | 1990 | 5 | 14 | 79% |
Antipyrine, theophylline, and hexobarbital as in vivo P450 probe drugs | 1996 | 2 | 18 | 67% |
DRUG-METABOLISM IN LIVER-DISEASE | 1989 | 65 | 71 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ZAKLAD CHEM FIZJOL | 4 | 75% | 0.4% | 3 |
2 | ZAKLAD CHEM FIZJOLOGICZNEJ | 4 | 75% | 0.4% | 3 |
3 | WYDZIAL BIOTECHNOL HODOWLI ZWIERZAT | 1 | 31% | 0.5% | 4 |
4 | KATEDRA FIZJOLOGII ZWIERZAT | 1 | 33% | 0.3% | 2 |
5 | PHARMACOKINET PHARMACODYNAM SECT | 1 | 29% | 0.3% | 2 |
6 | ANAT TOXICOL | 0 | 33% | 0.1% | 1 |
7 | ANALYT CHEM CERTIFICAT QUAL MANAGEMENT | 0 | 25% | 0.1% | 1 |
8 | 332 N LAUDERDALE | 0 | 11% | 0.3% | 2 |
9 | CLIN PEDIAT HEMATOL | 0 | 17% | 0.1% | 1 |
10 | EISAI S | 0 | 14% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000222717 | MONOETHYLGLYCINEXYLIDIDE//MEGX//C 13 METHACETIN |
2 | 0.0000142773 | CYP ISOZYMES//MOL RECOGNIT TECHNOL DEV IDM//CIENCIAS BASICAS FARMACEUT |
3 | 0.0000139919 | HEIDELBERG CAPSULE//ROXATIDINE ACETATE//SECT PEDIAT CLIN PHARMACOL TOXICOL |
4 | 0.0000128313 | AVITRIPTAN//ENVIRONM INJURY EPIDEMIOL TOXICOL UNIT//HOMICIDE PREVENTION |
5 | 0.0000125860 | CYP1A2//CAFFEINE METABOLISM//CYP1A2 ACTIVITY |
6 | 0.0000104723 | MED HOSP PHARM YAHATANISHI KU//4 HYDROXYPROPRANOLOL//PROPRANOLOL METABOLISM |
7 | 0.0000102102 | ROLLINS 5119//ANTIPYRINE PHARMACOKINETICS//CYTOCHROME P4502B1 2 |
8 | 0.0000097332 | HEPATIC AMINO NITROGEN CONVERSION//UREA SYNTHESIS//AMMONIOGENESIS |
9 | 0.0000084431 | ADITOPRIM//SULPHAMONOMETHOXINE//VET MED HERD HLTH AMBULATORY CLIN |
10 | 0.0000084071 | CAS 58 55 9//ABT BIOPHARM PHARMAKOKINETIK//BRONCHORETARD R |